NovoCure Ltd (NVCR) Company Profile & Statistics

NovoCure Ltd
NVCR
(Nasdaq - US)
Closed
91.11
-0.07 (-0.08%)
in:usd•As of: Feb 01, 2023 15:59 UTC -5
Open
91.48
High
93.24
Low
87.23

About NovoCure Ltd

CEO

Asaf Danziger

Headquarters

no. 4 the forum, grenville street

st. helier, y9 je2 4uf, jersey

Auditor

KOST FORER GABBAY & KASIERER

Employees

1,167

Share Holders

Website

www.novocure.com

Industry

medical specialties

Sector

health technology

Company Overview

NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.

NovoCure Ltd Statistics

Valuation Measures

Market Capitalization ²	9.56B
Enterprise Value	9.88B
Enterprise Value/EBITDA (ttm)	-173.93
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	21.38
Price to Sales (ttm)	17.55
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	78.65%
Operating Margin (ttm)	-15.05%
Profit Margin (ttm)	-15.14%
Return on Equity (ttm)	-18.85%
Return on Invested Capital (ttm)	-8.20%
Return on Assets (ttm)	-7.06%

Income Statement

Revenue (ttm)	542.62M
Revenue Per Share (ttm)	5.17
Gross Profit (ttm)	426.96M
EBITDA (ttm)³	-56.82M
Net Income Avi to Common (ttm)	-81.69M
Diluted EPS (ttm)	-0.77

Share Statistics

Beta (5Y Monthly)	0.78
52-Week Change	26.91%
S&P500 52-Week Change	-9.40%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	104.95M
Dividend Yield	0.00%
Float ⁴	98.42M
% Held by Insiders	6.22%
% Held by Institutions	78.42%

Balance Sheet

Total Cash (mrq)	970.55M
Total Cash Per Share (mrq)	9.25
Total Debt (mrq)	564.68M
Total Debt/Equity (mrq)	126.78%
Current Ratio (mrq)	7.81%
Quick Ratio (mrq)	7.62%
Book Value Per Share (mrq)	4.24

Cash Flow

Operating Cash Flow Per Share (ytd)	0.33
Free Cash Flow (ytd)	19.57M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NovoCure Ltd

Trade With A Regulated Broker